Hepatotoxicity in cancer patients receiving erb-38, a recombinant immunotoxin that targets the erbB2 receptor. [electronic resource]
Producer: 19991122Description: 2311-5 p. digitalISSN:- 1078-0432
- ADP Ribose Transferases
- Adult
- Alanine Transaminase -- metabolism
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Neoplasm -- biosynthesis
- Aspartate Aminotransferases -- metabolism
- Bacterial Toxins -- adverse effects
- Breast Neoplasms -- drug therapy
- Chemical and Drug Induced Liver Injury
- Esophageal Neoplasms -- drug therapy
- Exotoxins -- adverse effects
- Female
- Humans
- Immunotoxins -- adverse effects
- Liver -- drug effects
- Liver Diseases -- enzymology
- Male
- Middle Aged
- Receptor, ErbB-2 -- metabolism
- Recombinant Proteins -- adverse effects
- Virulence Factors
- Pseudomonas aeruginosa Exotoxin A
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.